Anti-viral treatment during pregnancy reduces HBV transmission from mother to child

April 24, 2017, Wiley

An analysis of published studies indicates that the antiviral drug tenofovir given to pregnant women in the second or third trimester can help prevent mother to child transmission of the hepatitis B virus (HBV).

Universal vaccination of newborn babies has brought down to 10-30%. In their Alimentary Pharmacology & Therapeutics analysis of data from five controlled trials, Dr. Ji Hoon Kim and his colleagues found that the risk of maternal transmission to the baby is further reduced, down to only 3% (77% reduction of transmission), when the mother receives the antiviral drug tenofovir during pregnancy.

Chronic HBV infection affects approximately 240 million people worldwide. Without treatment, it is transmitted from mother to baby in about 90% of births, often causing liver disease as the child grows up. More than 600,000 people die annually because of HBV complications.

Explore further: Antenatal screening in Europe: How to avoid mother-to-child transmission of infections

More information: M. H. Hyun et al, Systematic review with meta-analysis: the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus, Alimentary Pharmacology & Therapeutics (2017). DOI: 10.1111/apt.14068

Related Stories

Antenatal screening in Europe: How to avoid mother-to-child transmission of infections

March 21, 2017
Transmission of infections with HIV, hepatitis B, syphilis or rubella from mother to child before and during birth as well as in infancy still occur across Europe - despite existing prevention methods. A new ECDC report outlines ...

Tenofovir disoproxil fumarate can cut HBV transmission

June 16, 2016
(HealthDay)—Use of tenofovir disoproxil fumarate (TDF) during pregnancy can reduce the rate of mother-to-child transmission of hepatitis B virus (HBV), according to a study published in the June 16 issue of the New England ...

Drug prevents passage of HBV during pregnancy

June 1, 2015
The antiviral drug telbivudine prevents perinatal transmission of hepatitis B virus (HBV), according to a study in the June issue of Clinical Gastroenterology and Hepatology, the official clinical practice journal of the ...

Vaccination succeeds in dramatically reducing hepatitis B in NSW Aboriginal women

April 19, 2017
There has been a significant reduction in hepatitis B virus in Aboriginal women giving birth in NSW, with the decline linked to the introduction of the state's newborn vaccination program.

Mother-child HIV transmission at all time low in U.K. and Ireland

December 8, 2016
The number of mothers passing the HIV virus to their babies has fallen to a new record low in the UK and Ireland thanks to the very high take-up of antenatal HIV screening and treatment which reduces virus levels in the pregnant ...

Mother-to-child HIV transmission low, but more progress possible

March 13, 2017
(HealthDay)—A small proportion of HIV-infected women continue to transmit the virus to their neonates despite access to high-quality care, according to research published in the April issue of Obstetrics & Gynecology.

Recommended for you

Scientists gain new insight on how antibodies interact with widespread respiratory virus

February 22, 2018
Scientists have found and characterized the activity of four antibodies produced by the human immune system that target an important protein found in respiratory syncytial virus (RSV), according to new research published ...

Study reveals how kidney disease happens

February 22, 2018
Monash researchers have solved a mystery, revealing how certain immune cells work together to instigate autoimmune kidney disease.

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.